For example, it has the ability to target Mpro (SARS-CoV-2 3CL hydrolase), the main protease for SARS-CoV-2, or ACE2 (angiotensin-converting enzyme 2), the receptor for SARS-CoV-2, which may inhibit the development of COVID-19 [2,6]. This evidence concerns the gene ACE2 and COVID-19.